FDA fast-tracks topical drops for LHON

• Posted on: Dec 19 2017
• By: Saratoga Opthalmology
• Leave a response

Stealth BioTherapeutics has gained the fast-track designation for elamipretide, an eye drop aimed at improving mitochondrial function in individuals with Leber’s hereditary optic neuropathy (LHON).
Source: AAO

Posted in: Uncategorized